Particulate formulation for administration by inhalation
April 2, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3634582 3860618 Sodium chromoglycate inhalation medicament Powder composition for inhalation therapy Composition for treating airway disease Composition Pharmaceutical compositions containing sodium chromoglycate and 댢 selective bronchodilators Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases Aerosol carriers Aerosol formulations containing propellant 134a and fluticasone propionate Patent #: 5658549 InventorsAssigneeApplicationNo. 765928 filed on 04/02/1997US Classes:424/689, With stabilizer or suspending agent424/46Powder or dust containingExaminersPrimary: Bawa, RajAttorney, Agent or FirmForeign Patent References
International ClassA61K 009/14Foreign Application Priority Data1994-07-16 DEAbstractA pharmaceutical formulation for administration by inhalation, a micronized active compound or micronized active compound mixture with a mean particle size of 0.1 μm to 10 μm being applied to a pharmaceutically acceptable excipient having a mean particle size of 200 μm to 1000 μm without the use of binders.Other References
| |
